CD44 and breast carcinoma: As breast cancer stem cells are characterized as CD44 + /CD24 −  we trypsinized the MDA-MB-231 G85 and GNS spheres, stained them with CD44 and CD24 specific antibodies, and analyzed by flow cytometry.